Assure Tech Hangzhou Co Ltd (688075) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Assure Tech Hangzhou Co Ltd (688075) has a cash flow conversion efficiency ratio of 0.000x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-2.25 Million ≈ $-329.31K USD) by net assets (CN¥5.16 Billion ≈ $754.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Assure Tech Hangzhou Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Assure Tech Hangzhou Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 688075 total liabilities for a breakdown of total debt and financial obligations.
Assure Tech Hangzhou Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Assure Tech Hangzhou Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fujian Green Pine Co Ltd
SHE:300132
|
-0.038x |
|
Charter Hall Social Infrastructure REIT
AU:CQE
|
0.015x |
|
Paramount Global Class A
NASDAQ:PARAA
|
0.009x |
|
Alpha Hpa Ltd
AU:A4N
|
-0.107x |
|
Sansec Technology Co. Ltd. A
SHG:688489
|
N/A |
|
Beijing Fengshangshiji Culture Medi
SHE:300860
|
0.015x |
|
Zhengzhou Qianweiyangchu Food Co Ltd
SHE:001215
|
0.044x |
|
Zheshang Development Group Co Ltd
SHE:000906
|
-0.209x |
Annual Cash Flow Conversion Efficiency for Assure Tech Hangzhou Co Ltd (2017–2024)
The table below shows the annual cash flow conversion efficiency of Assure Tech Hangzhou Co Ltd from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Assure Tech Hangzhou Co Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥5.20 Billion ≈ $760.89 Million |
CN¥75.09 Million ≈ $10.99 Million |
0.014x | +111.83% |
| 2023-12-31 | CN¥5.11 Billion ≈ $747.13 Million |
CN¥-623.08 Million ≈ $-91.18 Million |
-0.122x | -117.67% |
| 2022-12-31 | CN¥5.42 Billion ≈ $792.94 Million |
CN¥3.74 Billion ≈ $547.76 Million |
0.691x | +166.38% |
| 2021-12-31 | CN¥2.61 Billion ≈ $381.41 Million |
CN¥675.94 Million ≈ $98.91 Million |
0.259x | -65.05% |
| 2020-12-31 | CN¥811.69 Million ≈ $118.78 Million |
CN¥602.20 Million ≈ $88.12 Million |
0.742x | +519.59% |
| 2019-12-31 | CN¥162.36 Million ≈ $23.76 Million |
CN¥19.44 Million ≈ $2.84 Million |
0.120x | +0.89% |
| 2018-12-31 | CN¥102.68 Million ≈ $15.02 Million |
CN¥12.19 Million ≈ $1.78 Million |
0.119x | -54.33% |
| 2017-12-31 | CN¥63.54 Million ≈ $9.30 Million |
CN¥16.51 Million ≈ $2.42 Million |
0.260x | -- |
About Assure Tech Hangzhou Co Ltd
Assure Tech (Hangzhou) Co., Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents, and instruments in China. It is also involved in POCT and plastic product manufacturing; online sales; pharmaceutical sales; and medical testing. In addition, the company offers drug of abuse, infectious disease, fertility, cardiac marker, tumor marker, allergen, and veteri… Read more